Malignant Ascites Treatment Market
PharmaCyte Biotech Inc., Sequana Medical, Fresenius SE & Co. KGaA, BioVie, BD, Medtronic plc, and GI Supply, Actavis Elizabeth LLC, Mylan Pharmaceuticals Inc., GE Healthcare, Trion Pharma, Siemens AG, and Fresenius Biotech are key players in the global malignant ascites treatment market. Major players are focusing on strategies such as collaboration and increased R&D funding to strengthen their product portfolio and maintain their market position. In 2016, for example, BioVie's Lead Compound BIV201 received FDA Orphan-Drug Designation for the treatment of ascites.
Read More:
https://knackersblogger.blogspot.com/2022/08/rising-prevalence-of-cirrhosis-is-major.html
